Aspectos imagiológicos da trombose venosa cerebral numa mulher grávida

Autor: Ferreira, MM, Rios, AC, Fragata, I, Baptista, JT, Manaças, R, Reis, J

Publikováno v: Acta Médica Portuguesa; v. 24, n. 1 (2011): Janeiro-Fevereiro; 193-198
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP

A trombose venosa cerebral (TVC) é uma doença relativamente rara mas grave, potencialmente reversível com diagnóstico atempado e terapêutica médica adequada. A gravidez e o puerpério são um factor predisponente de TVC, que é responsável por

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5d82e2f6e65c3c1258b3dac3aaf3a7b2
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/327

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Análisis, diseño e implementación de un sistema de información para la programación de cursos basados en competencias organizacionales en áreas de recursos humanos

Autor: Ríos Acosta, Roddy del Carmen

El presente trabajo de fin de carrera permitirá la implementación de un sistema de información cliente servidor para la programación de cursos basados en competencias organizacionales para áreas de recursos humanos. La necesidad del desarrollo d

Externí odkaz: http://hdl.handle.net/20.500.12404/18235

Human breast tissue engineering in health and disease.

Autor: Buchholz MB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Scheerman DI; Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands., Levato R; Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.; Department of Orthopedics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.

Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2024 Oct; Vol. 16 (10), pp. 2299-2321. Date of Electronic Publication: 2024 Aug 23.

BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response.

Autor: Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. malieva@iib.uam.es.; Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM), CSIC-UAM, Madrid, Spain. malieva@iib.uam.es., Barrera Román M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Petcu D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Zeeman AL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Dautzenberg NMM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., van de Ven C; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., Calkoen FGJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Clevers H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, the Netherlands.; Pharma, Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kuball J; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands.; Department of Hematology, UMC Utrecht, Utrecht University, Utrecht, the Netherlands., Sebestyén Z; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.

Publikováno v: Nature protocols [Nat Protoc] 2024 Jul; Vol. 19 (7), pp. 2052-2084. Date of Electronic Publication: 2024 Mar 19.